Advertisement
UK markets closed
  • NIKKEI 225

    39,341.54
    -325.53 (-0.82%)
     
  • HANG SENG

    17,716.47
    -373.46 (-2.06%)
     
  • CRUDE OIL

    81.81
    +0.91 (+1.12%)
     
  • GOLD FUTURES

    2,338.70
    +25.50 (+1.10%)
     
  • DOW

    39,164.06
    +36.26 (+0.09%)
     
  • Bitcoin GBP

    48,614.89
    +400.46 (+0.83%)
     
  • CMC Crypto 200

    1,281.85
    +15.70 (+1.24%)
     
  • NASDAQ Composite

    17,858.68
    +53.53 (+0.30%)
     
  • UK FTSE All Share

    4,460.27
    -20.39 (-0.46%)
     

Is Walgreens Boots Alliance (NASDAQ:WBA) A Risky Investment?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. We note that Walgreens Boots Alliance, Inc. (NASDAQ:WBA) does have debt on its balance sheet. But should shareholders be worried about its use of debt?

What Risk Does Debt Bring?

Debt and other liabilities become risky for a business when it cannot easily fulfill those obligations, either with free cash flow or by raising capital at an attractive price. In the worst case scenario, a company can go bankrupt if it cannot pay its creditors. However, a more usual (but still expensive) situation is where a company must dilute shareholders at a cheap share price simply to get debt under control. Having said that, the most common situation is where a company manages its debt reasonably well - and to its own advantage. The first thing to do when considering how much debt a business uses is to look at its cash and debt together.

See our latest analysis for Walgreens Boots Alliance

What Is Walgreens Boots Alliance's Net Debt?

The chart below, which you can click on for greater detail, shows that Walgreens Boots Alliance had US$13.0b in debt in February 2023; about the same as the year before. On the flip side, it has US$1.84b in cash leading to net debt of about US$11.2b.

debt-equity-history-analysis
debt-equity-history-analysis

How Healthy Is Walgreens Boots Alliance's Balance Sheet?

We can see from the most recent balance sheet that Walgreens Boots Alliance had liabilities of US$28.2b falling due within a year, and liabilities of US$42.7b due beyond that. Offsetting this, it had US$1.84b in cash and US$5.73b in receivables that were due within 12 months. So it has liabilities totalling US$63.3b more than its cash and near-term receivables, combined.

ADVERTISEMENT

The deficiency here weighs heavily on the US$30.5b company itself, as if a child were struggling under the weight of an enormous back-pack full of books, his sports gear, and a trumpet. So we'd watch its balance sheet closely, without a doubt. After all, Walgreens Boots Alliance would likely require a major re-capitalisation if it had to pay its creditors today.

We measure a company's debt load relative to its earnings power by looking at its net debt divided by its earnings before interest, tax, depreciation, and amortization (EBITDA) and by calculating how easily its earnings before interest and tax (EBIT) cover its interest expense (interest cover). This way, we consider both the absolute quantum of the debt, as well as the interest rates paid on it.

Walgreens Boots Alliance's debt is 3.6 times its EBITDA, and its EBIT cover its interest expense 3.1 times over. This suggests that while the debt levels are significant, we'd stop short of calling them problematic. Worse, Walgreens Boots Alliance's EBIT was down 67% over the last year. If earnings continue to follow that trajectory, paying off that debt load will be harder than convincing us to run a marathon in the rain. When analysing debt levels, the balance sheet is the obvious place to start. But it is future earnings, more than anything, that will determine Walgreens Boots Alliance's ability to maintain a healthy balance sheet going forward. So if you want to see what the professionals think, you might find this free report on analyst profit forecasts to be interesting.

Finally, while the tax-man may adore accounting profits, lenders only accept cold hard cash. So we always check how much of that EBIT is translated into free cash flow. Happily for any shareholders, Walgreens Boots Alliance actually produced more free cash flow than EBIT over the last three years. That sort of strong cash generation warms our hearts like a puppy in a bumblebee suit.

Our View

On the face of it, Walgreens Boots Alliance's EBIT growth rate left us tentative about the stock, and its level of total liabilities was no more enticing than the one empty restaurant on the busiest night of the year. But at least it's pretty decent at converting EBIT to free cash flow; that's encouraging. We're quite clear that we consider Walgreens Boots Alliance to be really rather risky, as a result of its balance sheet health. For this reason we're pretty cautious about the stock, and we think shareholders should keep a close eye on its liquidity. When analysing debt levels, the balance sheet is the obvious place to start. But ultimately, every company can contain risks that exist outside of the balance sheet. For example, we've discovered 1 warning sign for Walgreens Boots Alliance that you should be aware of before investing here.

Of course, if you're the type of investor who prefers buying stocks without the burden of debt, then don't hesitate to discover our exclusive list of net cash growth stocks, today.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here